These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

110 related articles for article (PubMed ID: 9256506)

  • 1. Deltorphin transport across the blood-brain barrier.
    Fiori A; Cardelli P; Negri L; Savi MR; Strom R; Erspamer V
    Proc Natl Acad Sci U S A; 1997 Aug; 94(17):9469-74. PubMed ID: 9256506
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Deltorphin II enhances extracellular levels of dopamine in the nucleus accumbens via opioid receptor-independent mechanisms.
    Murakawa K; Hirose N; Takada K; Suzuki T; Nagase H; Cools AR; Koshikawa N
    Eur J Pharmacol; 2004 Apr; 491(1):31-6. PubMed ID: 15102530
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Blockade of opioid receptors in rostral ventral medulla prevents antihyperalgesia produced by transcutaneous electrical nerve stimulation (TENS).
    Kalra A; Urban MO; Sluka KA
    J Pharmacol Exp Ther; 2001 Jul; 298(1):257-63. PubMed ID: 11408550
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A reappraisal of the role of the various opioid receptor subtypes in cell-mediated immunity.
    Caroleo MC; Arbitrio M; Melchiorri D; Nisticò G
    Neuroimmunomodulation; 1994; 1(2):141-7. PubMed ID: 7489325
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Delta opioid receptors mediate seizures produced by intrahippocampal injection of ala-deltorphin in rats.
    De Sarro GB; Marra R; Spagnolo C; Nisticò G
    Funct Neurol; 1992; 7(3):235-8. PubMed ID: 1323508
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Structure-activity relationships of a series of [D-Ala2]deltorphin I and II analogues; in vitro blood-brain barrier permeability and stability.
    Thomas SA; Abbruscato TJ; Hau VS; Gillespie TJ; Zsigo J; Hruby VJ; Davis TP
    J Pharmacol Exp Ther; 1997 May; 281(2):817-25. PubMed ID: 9152390
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Organic anion-transporting polypeptides mediate transport of opioid peptides across blood-brain barrier.
    Gao B; Hagenbuch B; Kullak-Ublick GA; Benke D; Aguzzi A; Meier PJ
    J Pharmacol Exp Ther; 2000 Jul; 294(1):73-9. PubMed ID: 10871297
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Dynorphinergic mechanism mediating endomorphin-2-induced antianalgesia in the mouse spinal cord.
    Wu HE; Sun HS; Darpolar M; Leitermann RJ; Kampine JP; Tseng LF
    J Pharmacol Exp Ther; 2003 Dec; 307(3):1135-41. PubMed ID: 14557378
    [TBL] [Abstract][Full Text] [Related]  

  • 9. In vivo pharmacological characterization of SoRI 9409, a nonpeptidic opioid mu-agonist/delta-antagonist that produces limited antinociceptive tolerance and attenuates morphine physical dependence.
    Wells JL; Bartlett JL; Ananthan S; Bilsky EJ
    J Pharmacol Exp Ther; 2001 May; 297(2):597-605. PubMed ID: 11303048
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Deltorphins: a family of naturally occurring peptides with high affinity and selectivity for delta opioid binding sites.
    Erspamer V; Melchiorri P; Falconieri-Erspamer G; Negri L; Corsi R; Severini C; Barra D; Simmaco M; Kreil G
    Proc Natl Acad Sci U S A; 1989 Jul; 86(13):5188-92. PubMed ID: 2544892
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Characterization of [3H]naltrindole binding to delta opioid receptors in mouse brain and mouse vas deferens: evidence for delta opioid receptor heterogeneity.
    Fang L; Knapp RJ; Horvath R; Matsunaga TO; Haaseth RC; Hruby VJ; Porreca F; Yamamura HI
    J Pharmacol Exp Ther; 1994 Feb; 268(2):836-46. PubMed ID: 8113996
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Buprenorphine antinociception is abolished, but naloxone-sensitive reward is retained, in mu-opioid receptor knockout mice.
    Ide S; Minami M; Satoh M; Uhl GR; Sora I; Ikeda K
    Neuropsychopharmacology; 2004 Sep; 29(9):1656-63. PubMed ID: 15100703
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Characterization of opioid receptors mediating stimulation of adenylate cyclase activity in rat olfactory bulb.
    Olianas MC; Onali P
    Mol Pharmacol; 1992 Jul; 42(1):109-15. PubMed ID: 1321951
    [TBL] [Abstract][Full Text] [Related]  

  • 14. New opioid receptor antagonist: Naltrexone-14-O-sulfate synthesis and pharmacology.
    Zádor F; Király K; Váradi A; Balogh M; Fehér Á; Kocsis D; Erdei AI; Lackó E; Zádori ZS; Hosztafi S; Noszál B; Riba P; Benyhe S; Fürst S; Al-Khrasani M
    Eur J Pharmacol; 2017 Aug; 809():111-121. PubMed ID: 28502630
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Brain microvessels take up large neutral amino acids in exchange for glutamine. Cooperative role of Na+-dependent and Na+-independent systems.
    Cangiano C; Cardelli-Cangiano P; James JH; Rossi-Fanelli F; Patrizi MA; Brackett KA; Strom R; Fischer JE
    J Biol Chem; 1983 Jul; 258(14):8949-54. PubMed ID: 6863319
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Involvement of central opioid systems in human interferon-alpha induced immobility in the mouse forced swimming test.
    Makino M; Kitano Y; Komiyama C; Hirohashi M; Takasuna K
    Br J Pharmacol; 2000 Jul; 130(6):1269-74. PubMed ID: 10903965
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Opioid agonist activity of ICI 174864 and its carboxypeptidase degradation product, LY281217.
    Cohen ML; Shuman RT; Osborne JJ; Gesellchen PD
    J Pharmacol Exp Ther; 1986 Sep; 238(3):769-72. PubMed ID: 2875170
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Synthesis and pharmacology of halogenated δ-opioid-selective [d-Ala(2)]deltorphin II peptide analogues.
    Pescatore R; Marrone GF; Sedberry S; Vinton D; Finkelstein N; Katlowitz YE; Pasternak GW; Wilson KR; Majumdar S
    ACS Chem Neurosci; 2015 Jun; 6(6):905-10. PubMed ID: 25844930
    [TBL] [Abstract][Full Text] [Related]  

  • 19. N-cyclobutylmethyl analog of normorphinone, N-CBM-TAMO: a short-term opioid agonist and long-term Mu-selective irreversible opioid antagonist.
    Xu JY; Seyed-Mozaffari A; Archer S; Bidlack JM
    J Pharmacol Exp Ther; 1996 Nov; 279(2):539-47. PubMed ID: 8930155
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Activity of mu- and delta-opioid agonists in vas deferens from mice deficient in MOR gene.
    Maldonado R; Severini C; Matthes HW; Kieffer BL; Melchiorri P; Negri L
    Br J Pharmacol; 2001 Apr; 132(7):1485-92. PubMed ID: 11264242
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.